Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Medicago USA has received the fourth milestone payment of $3.56m from the Defense Advanced Research Projects Agency (DARPA).
Subscribe to our email newsletter
The payment is a part of $21m DARPA milestone awards to be earned by Medicago under a technology investment agreement to demonstrate the scalable manufacturing of its plant-expressed VLP vaccines in US.
Medicago has received $19.8m to date for this project, with two milestones remaining.
Medicago US operations vice president Mike Wanner said that continuing to successfully advance the technology-transfer project is a further demonstration of their robust science and manufacturing platform.
"This milestone focused on documentation related to a phased commissioning approach to the cGMP facility and equipment," Wanner added.